Quantum量子訊息有限公司
← 最新全球產業報告

Optical Imaging Market

研究執行與發布:TechSci Research · 發布日期 2026-05-01 · 180 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 TechSci Research產業別 Healthcare & Life Sciences出版日期 2026-05-01頁數 180報告編號 TSR-7581

授權報價

Single User License$4,500 USD
Multiple User License$5,500 USD
Custom Research License$8,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Optical Imaging Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Optical Coherence Tomography (OCT), Near-infrared spectroscopy (NIRS), Hyperspectral Imaging (HIS), Photoacoustic Tomography (PAT)) By Product (Imaging System, Cameras, Lenses, Software, Others) By Therapeutic Area (Ophthalmology, Oncology, Dermatology, Neurology, Others) By Application (Pathological Imaging v/s Intraoperative Imaging) By End-User (Hospitals & Clinics, Diagnostic Imaging Centres, Research Laboratories, Others) By Region & Competition, 2021-2031F

報告摘要

Market Overview The global optical imaging market is projected to expand significantly, from USD 2.28 billion in 2025 to USD 4.34 billion by 2031, demonstrating an impressive compound annual growth rate (CAGR) of 11.32%. This growth is underpinned by optical imaging's ability to generate highly detailed visualizations of biological tissues and industrial materials through light interaction, offering a safer alternative to ionizing radiation. Key drivers include the increasing prevalence of chronic ophthalmic and neurological diseases, alongside the growing demand for automated quality control within manufacturing sectors. These factors represent a permanent shift towards more precise and safer diagnostic methods, with the foundational photonics market, which supports these imaging technologies, already exceeding $400 billion in value by 2025, according to SPIE, underscoring a strong industrial base. Despite this promising outlook, a significant hurdle to broader market penetration is the substantial acquisition cost of advanced imaging equipment. This financial barrier disproportionately affects developing economies and complicates reimbursement processes in established healthcare systems, hindering universal adoption. Consequently, these high capital requirements remain a formidable obstacle, limiting the widespread integration of optical solutions despite their recognized clinical and industrial advantages. Market Driver The market for optical imaging is significantly propelled by rapid technological advancements in Optical Coherence Tomography (OCT) and other sophisticated imaging systems, which are fundamentally reshaping the diagnostic landscape. These innovations empower clinicians to perform non-invasive assessments with micrometer-level precision, allowing for high-resolution, cross-sectional visualization of biological tissues. This capability is crucial for the early diagnosis of conditions such as retinal disorders and cardiovascular diseases, effectively mitigating the risks associated with conventional ionizing radiation. The tangible commercial impact of these technological strides is reflected in the strong financial performance of leading industry players; for instance, Topcon Corporation reported a 9.1% year-on-year revenue increase to 84.3 billion Japanese yen in its Eye Care business unit for FY2024, largely due to the robust adoption of advanced diagnostic solutions in North America and Europe. Another critical driver is the escalating prevalence of ophthalmic and chronic degenerative diseases, which necessitates frequent and accurate optical assessments. As the global geriatric population expands, the incidence of age-related conditions is accelerating, creating an urgent demand for scalable optical screening protocols to avert permanent disabilities. Data from Glaucoma.org in March 2025, indicating approximately 4.22 million glaucoma cases in the United States, underscores this growing burden and the imperative for continuous optical monitoring. Furthermore, the broader integration of optical technologies into endoscopic procedures for internal medicine is contributing to market expansion, as evidenced by Olympus Corporation's 7.7% increase in consolidated revenue to 997.3 billion Japanese yen in 2025, reflecting a surging global demand for therapeutic and diagnostic optical solutions in medical settings. Market Challenge The substantial acquisition costs associated with advanced optical imaging instrumentation represent a significant impediment to the growth of the global market. These considerable financial requirements create a formidable barrier to procurement, particularly within developing economies where healthcare budgets are stringently managed. Consequently, medical facilities in these regions often continue to utilize older technologies, which delays the transition to safer and more advanced optical modalities and leaves extensive potential markets largely untapped. Moreover, within established healthcare systems, the considerable capital outlay complicates reimbursement negotiations, frequently leading hospitals to defer crucial equipment upgrades and thereby hindering the rapid diffusion of technological advancements. This pronounced capital intensity also contributes to the consolidation of the industry's supply side, which in turn sustains elevated price points and limits competitive market dynamics. The enormous investment needed for manufacturing and R&D effectively restricts market leadership to a select group of well-funded corporations, thereby preventing smaller, innovative entities from entering and potentially driving down costs through increased competition. Industry data from SPIE in 2025 highlighted this structural consolidation, reporting that approximately 6% of companies in the photonics sector generated over 86% of the total industry revenue, underscoring the significant market concentration driven by financial barriers and ultimately restricting the universal adoption of these advanced diagnostic solutions. Market Trends The global optical imaging market is undergoing a significant transformation driven by the integration of artificial intelligence (AI) and deep learning, which is shifting the paradigm from static visualization to automated, predictive diagnostic platforms. This prominent trend involves the creation of proprietary algorithms capable of real-time pathology identification, thereby substantially reducing the interpretation workload for clinicians and markedly improving workflow efficiency. Manufacturers are actively capitalizing on this evolution by embedding advanced AI capabilities directly into their device ecosystems, developing high-value, interconnected solutions. For instance, Carl Zeiss Meditec AG's Annual Report for 2023/24 (December 2024) revealed that 16.6% of its total revenue was strategically allocated to research and development, primarily targeting advancements in these integrated, AI-driven digital workflow technologies for applications in ophthalmology and microsurgery. Concurrently, the market is experiencing a rapid proliferation of intraoperative optical imaging systems specifically designed to provide real-time surgical guidance. This trend encompasses the widespread deployment of fluorescence imaging and advanced endoscopy technologies, which enable surgeons to precisely visualize tissue perfusion and critical anatomical structures with high fidelity throughout surgical procedures. The immediate and demonstrable clinical value derived from these systems, particularly in reducing complication rates, is a primary catalyst for substantial procurement activities across hospital networks. Reflecting this trend, Stryker reported a 10.2% increase in full-year net sales to $22.6 billion in its 2024 Operating Results (January 2025), a growth trajectory largely fueled by the sustained global demand for its endoscopy and surgical visualization portfolios. Key Market Players * Canon Inc. * Nikon Corporation * Olympus Corporation * Fujifilm Holdings Corporation * Leica Microsystems GmbH * Thermo Fisher Scientific Inc. * Bruker Corporation * General Electric Company * Hologic, Inc. * Hitachi High-Technologies Corporation Report Scope In this report, the Global Optical Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # Optical Imaging Market, By Technique * Optical Coherence Tomography (OCT) * Near-infrared spectroscopy (NIRS) * Hyperspectral Imaging (HIS) * Photoacoustic Tomography (PAT) # Optical Imaging Market, By Product * Imaging System * Cameras * Lenses * Software * Others # Optical Imaging Market, By Therapeutic Area * Ophthalmology * Oncology * Dermatology * Neurology * Others # Optical Imaging Market, By Application * Pathological Imaging * Intraoperative Imaging # Optical Imaging Market, By End-User * Hospitals & Clinics * Diagnostic Imaging Centres * Research Laboratories * Others # Optical Imaging Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Optical Imaging Market. Available Customizations: Global Optical Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global Optical Imaging Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Technique (Optical Coherence Tomography (OCT), Near-infrared spectroscopy (NIRS), Hyperspectral Imaging (HIS), Photoacoustic Tomography (PAT)) 5.2.2. By Product (Imaging System, Cameras, Lenses, Software, Others) 5.2.3. By Therapeutic Area (Ophthalmology, Oncology, Dermatology, Neurology, Others) 5.2.4. By Application (Pathological Imaging v/s Intraoperative Imaging) 5.2.5. By End-User (Hospitals & Clinics, Diagnostic Imaging Centres, Research Laboratories, Others) 5.2.6. By Region 5.2.7. By Company (2025) 5.3. Market Map 6. North America Optical Imaging Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Technique 6.2.2. By Product 6.2.3. By Therapeutic Area 6.2.4. By Application 6.2.5. By End-User 6.2.6. By Country 6.3. North America: Country Analysis 6.3.1. United States Optical Imaging Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Technique 6.3.1.2.2. By Product 6.3.1.2.3. By Therapeutic Area 6.3.1.2.4. By Application 6.3.1.2.5. By End-User 6.3.2. Canada Optical Imaging Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Technique 6.3.2.2.2. By Product 6.3.2.2.3. By Therapeutic Area 6.3.2.2.4. By Application 6.3.2.2.5. By End-User 6.3.3. Mexico Optical Imaging Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Technique 6.3.3.2.2. By Product 6.3.3.2.3. By Therapeutic Area 6.3.3.2.4. By Application 6.3.3.2.5. By End-User 7. Europe Optical Imaging Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Technique 7.2.2. By Product 7.2.3. By Therapeutic Area 7.2.4. By Application 7.2.5. By End-User 7.2.6. By Country 7.3. Europe: Country Analysis 7.3.1. Germany Optical Imaging Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Technique 7.3.1.2.2. By Product 7.3.1.2.3. By Therapeutic Area 7.3.1.2.4. By Application 7.3.1.2.5. By End-User 7.3.2. France Optical Imaging Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Technique 7.3.2.2.2. By Product 7.3.2.2.3. By Therapeutic Area 7.3.2.2.4. By Application 7.3.2.2.5. By End-User 7.3.3. United Kingdom Optical Imaging Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Technique 7.3.3.2.2. By Product 7.3.3.2.3. By Therapeutic Area 7.3.3.2.4. By Application 7.3.3.2.5. By End-User 7.3.4. Italy Optical Imaging Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Technique 7.3.4.2.2. By Product 7.3.4.2.3. By Therapeutic Area 7.3.4.2.4. By Application 7.3.4.2.5. By End-User 7.3.5. Spain Optical Imaging Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Technique 7.3.5.2.2. By Product 7.3.5.2.3. By Therapeutic Area 7.3.5.2.4. By Application 7.3.5.2.5. By End-User 8. Asia Pacific Optical Imaging Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Technique 8.2.2. By Product 8.2.3. By Therapeutic Area 8.2.4. By Application 8.2.5. By End-User 8.2.6. By Country 8.3. Asia Pacific: Country Analysis 8.3.1. China Optical Imaging Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Technique 8.3.1.2.2. By Product 8.3.1.2.3. By Therapeutic Area 8.3.1.2.4. By Application 8.3.1.2.5. By End-User 8.3.2. India Optical Imaging Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Technique 8.3.2.2.2. By Product 8.3.2.2.3. By Therapeutic Area 8.3.2.2.4. By Application 8.3.2.2.5. By End-User 8.3.3. Japan Optical Imaging Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Technique 8.3.3.2.2. By Product 8.3.3.2.3. By Therapeutic Area 8.3.3.2.4. By Application 8.3.3.2.5. By End-User 8.3.4. South Korea Optical Imaging Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Technique 8.3.4.2.2. By Product 8.3.4.2.3. By Therapeutic Area 8.3.4.2.4. By Application 8.3.4.2.5. By End-User 8.3.5. Australia Optical Imaging Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Technique 8.3.5.2.2. By Product 8.3.5.2.3. By Therapeutic Area 8.3.5.2.4. By Application 8.3.5.2.5. By End-User 9. Middle East & Africa Optical Imaging Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Technique 9.2.2. By Product 9.2.3. By Therapeutic Area 9.2.4. By Application 9.2.5. By End-User 9.2.6. By Country 9.3. Middle East & Africa: Country Analysis 9.3.1. Saudi Arabia Optical Imaging Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Technique 9.3.1.2.2. By Product 9.3.1.2.3. By Therapeutic Area 9.3.1.2.4. By Application 9.3.1.2.5. By End-User 9.3.2. UAE Optical Imaging Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Technique 9.3.2.2.2. By Product 9.3.2.2.3. By Therapeutic Area 9.3.2.2.4. By Application 9.3.2.2.5. By End-User 9.3.3. South Africa Optical Imaging Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Technique 9.3.3.2.2. By Product 9.3.3.2.3. By Therapeutic Area 9.3.3.2.4. By Application 9.3.3.2.5. By End-User 10. South America Optical Imaging Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Technique 10.2.2. By Product 10.2.3. By Therapeutic Area 10.2.4. By Application 10.2.5. By End-User 10.2.6. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Optical Imaging Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Technique 10.3.1.2.2. By Product 10.3.1.2.3. By Therapeutic Area 10.3.1.2.4. By Application 10.3.1.2.5. By End-User 10.3.2. Colombia Optical Imaging Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Technique 10.3.2.2.2. By Product 10.3.2.2.3. By Therapeutic Area 10.3.2.2.4. By Application 10.3.2.2.5. By End-User 10.3.3. Argentina Optical Imaging Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Technique 10.3.3.2.2. By Product 10.3.3.2.3. By Therapeutic Area 10.3.3.2.4. By Application 10.3.3.2.5. By End-User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Global Optical Imaging Market: SWOT Analysis 14. Porter's Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. Canon Inc. 15.1.1. Business Overview 15.1.2. Products & Services 15.1.3. Recent Developments 15.1.4. Key Personnel 15.1.5. SWOT Analysis 15.2. Nikon Corporation 15.3. Olympus Corporation 15.4. Fujifilm Holdings Corporation 15.5. Leica Microsystems GmbH 15.6. Thermo Fisher Scientific Inc. 15.7. Bruker Corporation 15.8. General Electric Company 15.9. Hologic, Inc. 15.10. Hitachi High-Technologies Corporation 16. Strategic Recommendations 17. About Us & Disclaimer

提及公司

1 Canon Inc.2 Nikon Corporation3 Olympus Corporation4 Fujifilm Holdings Corporation5 Leica Microsystems GmbH6 Thermo Fisher Scientific Inc.7 Bruker Corporation8 General Electric Company9 Hologic, Inc.10 Hitachi High-Technologies Corporation

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 TechSci Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們